COVID-19 Eradication for Vaccine Equity in Low Income Countries
Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Dharmapalan, Dhanya [verfasserIn] John, T. Jacob [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Indian Academy of Pediatrics 2021 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Indian Pediatrics - Springer-Verlag, 2010, 58(2021), 10 vom: 09. Juni, Seite 970-972 |
|---|---|
| Übergeordnetes Werk: |
volume:58 ; year:2021 ; number:10 ; day:09 ; month:06 ; pages:970-972 |
| Links: |
|---|
| DOI / URN: |
10.1007/s13312-021-2333-0 |
|---|
| Katalog-ID: |
SPR045416141 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR045416141 | ||
| 003 | DE-627 | ||
| 005 | 20230519134050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211028s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13312-021-2333-0 |2 doi | |
| 035 | |a (DE-627)SPR045416141 | ||
| 035 | |a (SPR)s13312-021-2333-0-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dharmapalan, Dhanya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Indian Academy of Pediatrics 2021 | ||
| 520 | |a Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. | ||
| 650 | 4 | |a Herd effect |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Herd immunity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a SARS-CoV-2 |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a John, T. Jacob |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian Pediatrics |d Springer-Verlag, 2010 |g 58(2021), 10 vom: 09. Juni, Seite 970-972 |w (DE-627)SPR031274943 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2021 |g number:10 |g day:09 |g month:06 |g pages:970-972 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s13312-021-2333-0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_72 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_131 | ||
| 912 | |a GBV_ILN_160 | ||
| 912 | |a GBV_ILN_376 | ||
| 912 | |a GBV_ILN_607 | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2021 |e 10 |b 09 |c 06 |h 970-972 | ||
| author_variant |
d d dd t j j tj tjj |
|---|---|
| matchkey_str |
dharmapalandhanyajohntjacob:2021----:oi1eaiainovcieqiyno |
| hierarchy_sort_str |
2021 |
| publishDate |
2021 |
| allfields |
10.1007/s13312-021-2333-0 doi (DE-627)SPR045416141 (SPR)s13312-021-2333-0-e DE-627 ger DE-627 rakwb eng Dharmapalan, Dhanya verfasserin aut COVID-19 Eradication for Vaccine Equity in Low Income Countries 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Academy of Pediatrics 2021 Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 John, T. Jacob verfasserin aut Enthalten in Indian Pediatrics Springer-Verlag, 2010 58(2021), 10 vom: 09. Juni, Seite 970-972 (DE-627)SPR031274943 nnns volume:58 year:2021 number:10 day:09 month:06 pages:970-972 https://dx.doi.org/10.1007/s13312-021-2333-0 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 AR 58 2021 10 09 06 970-972 |
| spelling |
10.1007/s13312-021-2333-0 doi (DE-627)SPR045416141 (SPR)s13312-021-2333-0-e DE-627 ger DE-627 rakwb eng Dharmapalan, Dhanya verfasserin aut COVID-19 Eradication for Vaccine Equity in Low Income Countries 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Academy of Pediatrics 2021 Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 John, T. Jacob verfasserin aut Enthalten in Indian Pediatrics Springer-Verlag, 2010 58(2021), 10 vom: 09. Juni, Seite 970-972 (DE-627)SPR031274943 nnns volume:58 year:2021 number:10 day:09 month:06 pages:970-972 https://dx.doi.org/10.1007/s13312-021-2333-0 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 AR 58 2021 10 09 06 970-972 |
| allfields_unstemmed |
10.1007/s13312-021-2333-0 doi (DE-627)SPR045416141 (SPR)s13312-021-2333-0-e DE-627 ger DE-627 rakwb eng Dharmapalan, Dhanya verfasserin aut COVID-19 Eradication for Vaccine Equity in Low Income Countries 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Academy of Pediatrics 2021 Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 John, T. Jacob verfasserin aut Enthalten in Indian Pediatrics Springer-Verlag, 2010 58(2021), 10 vom: 09. Juni, Seite 970-972 (DE-627)SPR031274943 nnns volume:58 year:2021 number:10 day:09 month:06 pages:970-972 https://dx.doi.org/10.1007/s13312-021-2333-0 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 AR 58 2021 10 09 06 970-972 |
| allfieldsGer |
10.1007/s13312-021-2333-0 doi (DE-627)SPR045416141 (SPR)s13312-021-2333-0-e DE-627 ger DE-627 rakwb eng Dharmapalan, Dhanya verfasserin aut COVID-19 Eradication for Vaccine Equity in Low Income Countries 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Academy of Pediatrics 2021 Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 John, T. Jacob verfasserin aut Enthalten in Indian Pediatrics Springer-Verlag, 2010 58(2021), 10 vom: 09. Juni, Seite 970-972 (DE-627)SPR031274943 nnns volume:58 year:2021 number:10 day:09 month:06 pages:970-972 https://dx.doi.org/10.1007/s13312-021-2333-0 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 AR 58 2021 10 09 06 970-972 |
| allfieldsSound |
10.1007/s13312-021-2333-0 doi (DE-627)SPR045416141 (SPR)s13312-021-2333-0-e DE-627 ger DE-627 rakwb eng Dharmapalan, Dhanya verfasserin aut COVID-19 Eradication for Vaccine Equity in Low Income Countries 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Academy of Pediatrics 2021 Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 John, T. Jacob verfasserin aut Enthalten in Indian Pediatrics Springer-Verlag, 2010 58(2021), 10 vom: 09. Juni, Seite 970-972 (DE-627)SPR031274943 nnns volume:58 year:2021 number:10 day:09 month:06 pages:970-972 https://dx.doi.org/10.1007/s13312-021-2333-0 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 AR 58 2021 10 09 06 970-972 |
| language |
English |
| source |
Enthalten in Indian Pediatrics 58(2021), 10 vom: 09. Juni, Seite 970-972 volume:58 year:2021 number:10 day:09 month:06 pages:970-972 |
| sourceStr |
Enthalten in Indian Pediatrics 58(2021), 10 vom: 09. Juni, Seite 970-972 volume:58 year:2021 number:10 day:09 month:06 pages:970-972 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Herd effect Herd immunity SARS-CoV-2 |
| isfreeaccess_bool |
false |
| container_title |
Indian Pediatrics |
| authorswithroles_txt_mv |
Dharmapalan, Dhanya @@aut@@ John, T. Jacob @@aut@@ |
| publishDateDaySort_date |
2021-06-09T00:00:00Z |
| hierarchy_top_id |
SPR031274943 |
| id |
SPR045416141 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR045416141</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519134050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">211028s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13312-021-2333-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR045416141</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13312-021-2333-0-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dharmapalan, Dhanya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">COVID-19 Eradication for Vaccine Equity in Low Income Countries</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Indian Academy of Pediatrics 2021</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herd effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herd immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">SARS-CoV-2</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John, T. Jacob</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Indian Pediatrics</subfield><subfield code="d">Springer-Verlag, 2010</subfield><subfield code="g">58(2021), 10 vom: 09. Juni, Seite 970-972</subfield><subfield code="w">(DE-627)SPR031274943</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">day:09</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:970-972</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13312-021-2333-0</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_72</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_160</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_376</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_607</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="b">09</subfield><subfield code="c">06</subfield><subfield code="h">970-972</subfield></datafield></record></collection>
|
| author |
Dharmapalan, Dhanya |
| spellingShingle |
Dharmapalan, Dhanya misc Herd effect misc Herd immunity misc SARS-CoV-2 COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| authorStr |
Dharmapalan, Dhanya |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR031274943 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
COVID-19 Eradication for Vaccine Equity in Low Income Countries Herd effect (dpeaa)DE-He213 Herd immunity (dpeaa)DE-He213 SARS-CoV-2 (dpeaa)DE-He213 |
| topic |
misc Herd effect misc Herd immunity misc SARS-CoV-2 |
| topic_unstemmed |
misc Herd effect misc Herd immunity misc SARS-CoV-2 |
| topic_browse |
misc Herd effect misc Herd immunity misc SARS-CoV-2 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Indian Pediatrics |
| hierarchy_parent_id |
SPR031274943 |
| hierarchy_top_title |
Indian Pediatrics |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR031274943 |
| title |
COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| ctrlnum |
(DE-627)SPR045416141 (SPR)s13312-021-2333-0-e |
| title_full |
COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| author_sort |
Dharmapalan, Dhanya |
| journal |
Indian Pediatrics |
| journalStr |
Indian Pediatrics |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
txt |
| container_start_page |
970 |
| author_browse |
Dharmapalan, Dhanya John, T. Jacob |
| container_volume |
58 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Dharmapalan, Dhanya |
| doi_str_mv |
10.1007/s13312-021-2333-0 |
| author2-role |
verfasserin |
| title_sort |
covid-19 eradication for vaccine equity in low income countries |
| title_auth |
COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| abstract |
Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. © Indian Academy of Pediatrics 2021 |
| abstractGer |
Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. © Indian Academy of Pediatrics 2021 |
| abstract_unstemmed |
Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. © Indian Academy of Pediatrics 2021 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_70 GBV_ILN_72 GBV_ILN_110 GBV_ILN_131 GBV_ILN_160 GBV_ILN_376 GBV_ILN_607 |
| container_issue |
10 |
| title_short |
COVID-19 Eradication for Vaccine Equity in Low Income Countries |
| url |
https://dx.doi.org/10.1007/s13312-021-2333-0 |
| remote_bool |
true |
| author2 |
John, T. Jacob |
| author2Str |
John, T. Jacob |
| ppnlink |
SPR031274943 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s13312-021-2333-0 |
| up_date |
2024-07-03T15:51:41.744Z |
| _version_ |
1803573685645213696 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR045416141</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519134050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">211028s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13312-021-2333-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR045416141</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13312-021-2333-0-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dharmapalan, Dhanya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">COVID-19 Eradication for Vaccine Equity in Low Income Countries</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Indian Academy of Pediatrics 2021</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herd effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herd immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">SARS-CoV-2</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John, T. Jacob</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Indian Pediatrics</subfield><subfield code="d">Springer-Verlag, 2010</subfield><subfield code="g">58(2021), 10 vom: 09. Juni, Seite 970-972</subfield><subfield code="w">(DE-627)SPR031274943</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">day:09</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:970-972</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13312-021-2333-0</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_72</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_160</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_376</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_607</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="b">09</subfield><subfield code="c">06</subfield><subfield code="h">970-972</subfield></datafield></record></collection>
|
| score |
7.401046 |